Agile Therapeutics, Inc. Announces A Poster Presentation Of Its SECURE Phase III Study At The Conference Post author:Sam Post published:March 16, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Slaps Partial Hold on 3 of Bristol-Myers Squibb's Opdivo-Based Combo Trials September 6, 2017 Rubius Therapeutics Raises $100 Million in Crossover Financing February 28, 2018 PURE Bioscience Receives FDA Interim Safety Determination Authorization To Test Higher Concentrations Of SDC-Based PURE Control Antimicrobial As A Poultry Processing Aid February 5, 2017
PURE Bioscience Receives FDA Interim Safety Determination Authorization To Test Higher Concentrations Of SDC-Based PURE Control Antimicrobial As A Poultry Processing Aid February 5, 2017